Patent details

EP2552441 Title: USES OF DGAT1 INHIBITORS

Basic Information

Publication number:
EP2552441
PCT Application Number:
PCT/US/2011/030234
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117153296
PCT Publication Number:
WO/2011/123401
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USES OF DGAT1 INHIBITORS
French Title of Invention:
UTILISATIONS D'INHIBITEURS DE DGAT1
German Title of Invention:
VERWENDUNG VON DGAT1-HEMMERN
SPC Number:

Dates

Filing date:
29/03/2011
Grant date:
04/05/2016
EP Publication Date:
04/05/2016
PCT Publication Date:
06/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/02/2013
EP B1 Publication Date:
04/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/03/2017
Expiration date:
29/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/03/2011
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
SERRANO-WU Michael H.
Address:
United States (US)

2

Name:
MEYERS Charles
Address:
United States (US)

3

Name:
THUREN Tom
Address:
United States (US)

Priority

Priority Number:
318814 P
Priority Date:
30/03/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/42;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages